13G Filing: Opaleye Management and Inotek Pharmaceuticals Corp (ITEK)
...... (read more)
Hedge Fund - Opaleye Management
Get Email AlertsJames A. Silverman Bio, Returns, AUM, Net Worth
Manager biography is currently missing.
Fund Profile
Filing Period:
| Fund Name: | Opaleye Management |
| Manager | James A. Silverman |
| Portfolio Value | $312,298,000 |
| Change This QTR | +1.10% |
Top 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|---|
| 1. | AXGN | 1,970,000 | $55,751 | 17.85% | ||
| 2. | Blueprint Medicines | 735,000 | $55,426 | 17.74% | ||
| 3. | FGEN | 360,000 | $17,064 | 5.46% | ||
| 4. | LOXO | 176,300 | $14,841 | +36% | 4.75% | |
| 5. | IMMU | 898,800 | $14,524 | 4.65% |
Latest 13D & 13G Filings
| Company | Symbol | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2018-02-09 | ||||
| 2018-02-09 | ||||
| 2018-02-09 | ||||
| 2018-02-09 |
News, Interviews and Investor Letters
This Healthcare Fund Just Had A Huge Q3: Here’s How
The mainstream media likes taking shots at hedge funds because they are easy targets. These investment vehicles are usually run by very wealthy individuals, who often make loads of money even when their...... (read more)
More Than 60% Returns For These Two Hedgies’ Favorite Health Care Picks
The health care sector has appreciated by nearly 30% over the past year. We decided to take a look at three companies that two health care-focused funds, namely James A. Silverman's Opaleye Managment...... (read more)
